Testing a device feature to reduce interference in heart monitoring

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study involves participants who already have a subcutaneous ICD device implanted and are attending a routine follow-up appointment. The goal is to evaluate a feature that can distinguish between muscle movements and irregular heart signals during simple arm exercises. Participants will be randomly assigned to have this feature either activated or deactivated during the exercises, with data collected in both scenarios. The study requires only one visit for participation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* At least 18 years of age
* Implanted EMBLEM S-ICD (Model A 209 and Model A 219, Boston Scientific, St Paul, MN, USA)

Exclusion Criteria:

* Less than 18 years of age
* Hemodynamically unstable
* Inability to preform TET due to orthopedic issues or cognitive impairment

Where it's running

• Medical University of South Carolina
  Charleston, South Carolina, United States Recruiting

Study contacts

• Principal investigator: Michael R Gold, MD, PhD — Medical University of South Carolina
• Study coordinator: Debi Everidge
• Email: adamsde@musc.edu
• Phone: 843-792-2944

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Sex differences in how cannabis affects people who regularly use it

  This Phase 2 trial tests whether men and women who use cannabis several days a week respond differently to THC versus placebo.

  Recruiting Phase 2 Medical University of South Carolina · Charleston, South Carolina · NCT07815691

• taVNS added to oral motor training for babies with severe swallowing trouble

  This trial tests whether pairing a noninvasive taVNS treatment with oral sensorimotor training helps infants in NICUs swallow better and feed more safely.

  Recruiting Medical University of South Carolina · Charleston, South Carolina · NCT07802301

• Personalized chemoimmunotherapy for early TNBC with high TILs (no anthracyclines upfront)

  This trial tests a 12-week, anthracycline-free neoadjuvant regimen of carboplatin, paclitaxel, and pembrolizumab in early-stage TNBC with high TILs to see if surgery outcomes are as good as historical regimens.

  Recruiting Phase 2 Medical University of South Carolina · Syracuse, New York and 1 other locations · NCT07743190

• Parietal brain stimulation for memory in Parkinson’s with mild cognitive impairment

  This study tests whether a short, high-dose burst of brain stimulation to the right superior parietal area can safely and feasibly help people with Parkinson’s-related cognitive impairment.

  Recruiting Medical University of South Carolina · Charleston, South Carolina · NCT07701785

• Smell training plus non-invasive nerve stimulation to boost sense of smell

  This test will try adding non-invasive trigeminal nerve stimulation to standard smell training for adults with smell loss to see if it improves olfactory function.

  Recruiting Phase 2 Medical University of South Carolina · Charleston, South Carolina · NCT07689773

• Olfactory-focused low-intensity ultrasound on smell perception in healthy adults

  This study tests whether gentle, targeted ultrasound can change how healthy adults perceive odors and respond to them.

  Recruiting Medical University of South Carolina · Charleston, South Carolina · NCT07658365

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.